SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Catalent and Lonza's Imbruvica contracts safe says AbbVie, post $21bn acq

AbbVie has closed the acquisition of Pharmacyclics and confirms it will continue to outsource manufacture the oncology drug Imbruvica.

Roundup of recent top CRO/CMO news

From new service offerings to manufacturing deals to more formal strategic partnerships, the world of contract research and manufacturing organizations has been busy as of late. Here’s a roundup of some of the deals and new offerings:

Parexel makes fourth upgrade to its randomization and trial supply management service

The fourth generation of enhancements to Parexel’s Randomization and Trial Supply Management (RTSM) service aims to simplify patient randomization and clinical supply management to reduce delivery timelines.

LabCorp outlines near-term goals following Covance integration

With the integration of Covance moving along steadily, Dave King, chairman and CEO of LabCorp, told investors last week at the UBS Healthcare Conference that LabCorp is ramping up a series of initiatives that will lead to $300m (€276m) in new revenue opportunities.

Lonza set to get commercial Adva-27a contract if cancer drug is approved

Lonza shipped a sample batch of a drug for resistant cancers this week and is set produce commercial supplies if it goes on to be approved says Sunshine Biopharma.

Merck Millipore nabs Singulex’s protein detection technology

Merck Millipore has entered an agreement whereby it will control and manage the Singulex Life Science Research business, which offers a technology that can provide ultra-sensitive protein detection. 

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...